Apr 23, 2014 at 21:29 | Source: PTI
The 5.5 years bonds were priced at a spread of 280 basis points and was oversubcribed 3.4 times with demand from 150 investors, Union Bank of India said in a statement.
Apr 23, 2014 at 19:42 | Source: CNBC-TV18
According to sources, Sahara has put two of its properties in Maharashtra on the block. One located in Pune is spread across 107 acres while the other in Solapur is about 108 acres.
Apr 23, 2014 at 18:07 | Source: Moneycontrol.com
The 1.45 crore initial public offer of Wonderla Holidays has received overwhelming response from investors, subscribing 37.80 times on Wednesday, as per data available on the exchange website.
Apr 23, 2014 at 16:40 | Source: CNBC-TV18
According to Siddharth Bhamre of Angel Borking there is not much point in doing positive trade just for an election outcome but thinks investors are sure to make more out this situation than traders.
Apr 23, 2014 at 16:01 | Source: Moneycontrol.com
Brokerage house ICICIdirect.com has recommended investors to hold HDFC Bank, Sesa Sterlite and LIC Housing Finance for the target price of Rs 750, Rs 175 and Rs 270 respectively, in its April 2014 research reports.
Apr 23, 2014 at 15:58 | Source: Moneycontrol.com
Emkay Global Financial Services has recommended investors to hold HDFC Bank and reduce Persistent Systems for the target price of Rs 760 and Rs 930 respectively, in its research reports dated April 22, 2014.
Apr 23, 2014 at 14:53 | Source: CNBC
That hasn`t stopped investors from chasing bonds` payouts. So far this year, USD 56.69 billion has flowed into bond funds, outpacing the USD 44.06 billion heading into equities, according to data from Jefferies.
Apr 23, 2014 at 12:12 | Source: Moneycontrol.com
Jaihind Synthetics has informed that a meeting of the Board of Directors of the Company will be held on April 30, 2014, in respect of issue of warrants, of the Company and to consider, and finalise the list of proposal of strategic investor for issue of 5,00,00,000 warrants.
Apr 23, 2014 at 11:50 | Source: Moneycontrol.com
Investors continued to buy shares of drug maker Lupin on Wednesday after the company has entered into a strategic joint venture agreement with Toyama-based Japanese pharmaceuticals company, Yoshindo Inc to create a new entity, YL Biologics (YLB).
Apr 23, 2014 at 10:58 | Source: CNBC-TV18
Gautam Chhaochharia, Head of India Research of UBS advises investors to add cyclicals and banks on positive poll outcome.